Virus-inactivated plasma - Plasmasafe: A one-year experience

Blood Transfusion

Volumn 5, Issue 3, 2007, Pages 134-142

  De Silvestro, Giustina ^a,c   Bagatella, Paola ^a,b   Tison, Tiziana ^a   Quaino, Vania ^a   Carraro, Paolo ^a   Tenderini, Maria Luisa ^a   Lazzaro, Annarosa ^a   Marotti, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Clinical effectiveness; Haemovigilance; PlasmaSafe; Solvent detergent technique

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; PROTEIN S;

ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FIBRINOGEN BLOOD LEVEL; HEART SURGERY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PROTHROMBIN TIME; QUALITY CONTROL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INACTIVATION;

EID: 47749153754     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2007.0004-07     Document Type: Article

References (28)

1. Consiglio Regionale del Veneto: Quarto Piano Sangue e Plasma Regionale. Available at: http://www.consiglio.regione.veneto.it/commissioni/ quintacommissione/allegati/pianoSangueApprovazione.pdf.
2. Flesland O, Seghatchian J, Solheim BG. The Norwegian plasma fractionation project: a 12 year clinical and economic success story. Transfus Apher Sci 2003; 28: 93-100.
3. Chekrizova V, Murphy WG. Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies. Transfus Med 2006; 16: 85-91,
4. Aznar JA, Bonanad S, Montoro JM, et al. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants. Vox Sang 2000; 79: 156-60.
5. Atance R, Pereira A, Ramirez B. Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion 2001; 41: 1548-52.
6. Williamson L, Murphy M. Update on the project to provide imported methylene blue treated fresh frozen plasma. Blood Matters Spring 2003; 12: 2-4. Available at: http://www.blood.co.uk/hospitals/library/pdf/bm12. pdf.
7. Doyle S, O'Brien P, Murphy K, et al. Coagulation factor content of solvent-detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003; 14: 283-7.
8. Yarranton H, Cohen H, Pavord SR, et al. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 2003; 121: 778-85.
9. Murphy K, O'Brien P, O'Donnell J. Acquired protein S deficiency in thrombotic thrombocytopenic purpura patients receiving solvent/detergent plasma exchange. Br J Haematol 2003; 122: 518-9.
10. Yarranton H, Lawrie AS, Purdy G, et al. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med 2004, 14: 39-44.
11. Yarranton H, Cohen H, Pavord SR. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 2003; 121: 776-85.
12. Garwood M, Cardigan RA, Drummond O, et al. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma. Transfusion 2003; 43: 1238-47.
13. Seghatchian J, Krailadsiri P. What's happening? The quality of methylene blue treated FFP and cryo. Transfus Apher Sci 2001; 25: 227-31.
14. Depasse F, Sensebé L, Seghatchian J, et al. The influence of blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerization indices. Transfus Apher Sci 2005; 33: 63-9.
15. Hellstern P. Solvent/detergent-treated plasma: composition, efficacy, and safety. Curr Opin Hematol 2004; 11: 346-50.
16. Regan F, Taylor C. Blood transfusion medicine. BMJ 2002; 325: 143-7.
17. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
18. Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity. Blood 1999; 94: 3922-7.
19. Haubelt H, Blome M, Kiessling AH, et al. Effects of solvent/detergent- treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sang 2002; 82: 9-14.
20. Hellstern P, Haubelt H. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy. Thromb Res 2002; 107 (Suppl 1); S3-8.
21. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, et al. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med 2002; 126: 1349-66.
22. Horowitz MS, Petha JC. SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sang 1998; 1: 231-5.
23. Santagostino E, Mancuso ME, Morfini M, et al. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica 2006; 91: 634-9.
24. McCarthy LJ. The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma [letter]. Br J Haematol 2006; 133: 107.
25. Barz D, Budde U, Hellstern P. Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes. Thromb Res 2002; 107: S23-S7.
26. Rock G, Yousef H, Neurath D, et al. ADAMTS-13 in fresh, stored, and solvent/detergent-treated plasma [letter]. Transfusion 2006; 46: 1261-2.
27. Riedler GF, Haycox AR, Duggan AK, et al. Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma. Vox Sang 2003; 85: 88-95.
28. Sachs UJH, Kauschat D, Bein G. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005; 45: 1628-31.